Thomas Norton, MD
Ophthalmology · Alexandria, LANPI 1801856232
Payments from drug & device makers
Across 188 payments — averaging $45.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$4K
- Glaukos Corporation$1K
- AbbVie$566
- Sight Sciences, Inc.$413
- Johnson & Johnson Surgical Vision, Inc.$306
- Mallinckrodt Hospital Products Inc.$298
- plus $2K from 24 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 62 | $3,674 |
| Glaukos Corporation | 14 | $1,327 |
| AbbVie(2 entities) | 18 | $566 |
| Sight Sciences, Inc. | 14 | $413 |
| Johnson & Johnson Surgical Vision, Inc. | 8 | $306 |
| Mallinckrodt Hospital Products Inc. | 7 | $298 |
| Biotissue Holdings Inc. | 4 | $259 |
| Ivantis, Inc | 2 | $225 |
| Genentech USA, Inc. | 4 | $180 |
| Rxsight Inc | 5 | $177 |
| Aerie Pharmaceuticals, Inc. | 3 | $156 |
| Sun Pharmaceutical Industries Inc. | 7 | $140 |
| Ocular Therapeutix, Inc. | 9 | $133 |
| Oyster Point Pharma, Inc. | 5 | $95 |
| Amgen(2 entities) | 4 | $70 |
| Bausch & Lomb Americas Inc. | 3 | $58 |
| Iridex Corporation | 1 | $53 |
| Merz Pharmaceuticals, LLC | 2 | $50 |
| Omeros Corporation | 3 | $40 |
| Rayner Intraocular Lenses Limited | 2 | $37 |
| Apellis Pharmaceuticals, Inc. | 1 | $32 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Novartis | 2 | $25 |
| Shire North American Group Inc | 1 | $25 |
| Eyepoint US, Inc. | 1 | $25 |
| Tarsus Pharmaceuticals, Inc. | 1 | $23 |
| Nova Eye, Inc. | 1 | $22 |
| Dompe US, Inc. | 1 | $21 |
| Biogen | 1 | $16 |
| Astellas Pharma US Inc | 1 | $15 |
How this compares
$8,482 in reported general payments places this provider in the 90th percentile of 286 ophthalmology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Alexandria
- Eric ReishAlexandria$158K
- Michael RedmondAlexandria$24K
- Patrick RedmondAlexandria$13K
- Blake WilliamsonBaton Rouge$482K
- William ReadMonroe$303K
- Delmar CaldwellNew Orleans$282K
- Ruben GrigorianWest Monroe$192K
- Wyche ColemanShreveport$130K
- Ze ZhangNew Orleans$103K
- Rebecca MetzingerNew Orleans$63K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.